Le Lézard
Classified in: Health
Subjects: PDT, WOM

Dealing with Hormonal Imbalance? FemarelleŽ Will Rejuvenate Your Life


FORT LAUDERDALE, Fla., Nov. 25, 2020 /PRNewswire/ -- It is possible to age with grace. But that does not mean it is always going to be easy. Over time, your body will change, and your moods will likely ebb and flow along with it. That said, you can stay on top of your health without losing ownership of yourself. FemarelleŽ offers a natural way to maintain a sense of control, even as nature takes its course. Under the guidance of parent company, Se-cure Pharmaceuticals, FemarelleŽ provides a chance to restore your body's hormonal balance with their new supplement, Rejuvenate.

Founded in 1997, Se-cure Pharmaceuticals Inc. develops proprietary botanical therapies using cutting-edge scaling technologies. With their FemarelleŽ brand, they developed innovative research and special biochemical agents that target specific tissues in a natural, safe, and effective way. The founder and CEO of Se-cure Pharmaceuticals was inspired to create a company by his mother's own personal experience with menopause following breast cancer and her inability to use hormonal therapy. As a result, FemarelleŽ's three flagship products suggest an alternative to hormonal therapies. Of the three offerings, FemarelleŽ's Rejuvenate supplement aims to maintain the effect of estrogen, even as the levels begin to decline for most women in their mid-forties.

At the onset of hormonal decline, many women notice a difference in their body behavior. The hormonal fluctuations often trigger a decreased libido, as well as changes in mood, energy level, temperament, sleep pattern, and skin elasticity. Rejuvenate is intended for women just embarking on this journey, as a means to provide proper health management when symptoms first appear.

With 56 capsules per pack and a twice-daily recommended dosage, FemarelleŽ Rejuvenate aims to offer a natural solution to many of the primary symptoms of hormonal decline. The understanding that lies behind the product is that the hormonal imbalance is a natural process, but its symptoms can have a significant negative impact on a women's well-being. Some available treatments offer a relief in symptoms at the cost of increasing potential health risks. FemarelleŽ is not recognized by the body as a hormone, but it targets the estrogen receptors, enabling women swift relief of unwanted symptoms in a safe and scientifically proven manner.

The soy found in FemarelleŽ Rejuvenate is not an isoflavones extract. Instead, the supplement is manufactured through a proprietary process. creating a stable and effective nutraceutical that is backed by multiple studies and supported by leading gynecologists around the world. As with all of the FemarelleŽ product line, FemarelleŽ Rejuvenate is gluten-free, glucose-free, non-GMO, and is manufactured in a plant that is GMP, ISO-9001, and HACCP-certified.

Respected figures in the women's healthcare community have spoken positively of FemarelleŽ products, including Dr. Lila Nachtigall, the former President of the North American Menopause Society and Director of Women's Wellness Program. According to Dr. Nachtigall: "I started recommending Femarelle to my patients after I visited the plant where FemarelleŽ is manufactured and I saw that there was really great quality control. I have seen it is very safe and effective through several studies that I conducted, and the results of the numerous studies done on the products."

FemarelleŽ Rejuvenate just might be the ideal alternative when managing your feminine health. Forty-five is the new thirty-five, and you should be able to just enjoy your life, because you deserve it.

SOURCES

https://www.femarelle.us/faq-s 

Please direct inquiries to:
Ruben Yamamoto
(954) 869-4676
[email protected] 

 

SOURCE Femarelle


These press releases may also interest you

at 18:30
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Bob Dagher to Executive Vice President and Chief Medical Officer. In addition, after four...

at 18:16
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 17:56
The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.  The budget increases tobacco taxes by $4.00 per carton of 200 cigarettes effective at midnight, and increases e-cigarette taxes by 12%...

at 17:45
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to...

at 17:31
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...

at 17:26
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIREŽ (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...



News published on and distributed by: